Keyphrases
Targeted Therapy
100%
Mandible
100%
Ameloblastoma
100%
Neoadjuvant
100%
Organ Preservation
100%
Preservation Approaches
100%
Preservation Surgery
50%
Dabrafenib
33%
BRAF V600E mutation
33%
BRAF Inhibitor (BRAFi)
33%
Adverse Effects
16%
Functional Impairment
16%
Psychological Impairment
16%
Pathological Response
16%
Effective Strategies
16%
After Surgery
16%
Tolerability
16%
Treatment Duration
16%
Dose Adjustment
16%
Aesthetic Impairment
16%
Treatment Regimen
16%
Hepatitis
16%
Sustained Response
16%
Partial Response
16%
Residual Tumor
16%
Immediate Reconstruction
16%
Radiological Response
16%
Tumor Response
16%
BRAF Inhibition
16%
Trametinib
16%
Treatment Interruption
16%
Bone Resection
16%
SAFE Strategy
16%
Odontogenic Neoplasm
16%
Ablative Surgery
16%
Tumor Enucleation
16%
Functional Aesthetics
16%
Retrospective Data Collection
16%
Complete Radiological Response
16%
Resection Reconstruction
16%
Near-complete Response
16%
Surgically Treated
16%
Medicine and Dentistry
Targeted Therapy
100%
Lower Jaw
100%
Ameloblastoma
100%
Neoplasm
33%
Dabrafenib
33%
Recurrent Disease
16%
Treatment Duration
16%
Adverse Event
16%
Enucleation
16%
Odontogenic Tumor
16%
Ablation Therapy
16%
Treatment Interruption
16%
Bone Resection
16%
Jaw
16%
Trametinib
16%